Cargando…
The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit
We estimated the harm related to medication delivery delays across 12,474 medication administration instances in an intensive care unit using retrospective data in a large urban academic medical center between 2012 and 2015. We leveraged an instrumental variables (IV) approach that addresses unobser...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774917/ https://www.ncbi.nlm.nih.gov/pubmed/35052199 http://dx.doi.org/10.3390/healthcare10010035 |
_version_ | 1784636458164813824 |
---|---|
author | Meng, Lesley Laudanski, Krzysztof Restrepo, Mariana Huffenberger, Ann Terwiesch, Christian |
author_facet | Meng, Lesley Laudanski, Krzysztof Restrepo, Mariana Huffenberger, Ann Terwiesch, Christian |
author_sort | Meng, Lesley |
collection | PubMed |
description | We estimated the harm related to medication delivery delays across 12,474 medication administration instances in an intensive care unit using retrospective data in a large urban academic medical center between 2012 and 2015. We leveraged an instrumental variables (IV) approach that addresses unobserved confounds in this setting. We focused on nurse shift changes as disruptors of timely medication (vasodilators, antipyretics, and bronchodilators) delivery to estimate the impact of delay. The average delay around a nurse shift change was 60.8 min (p < 0.001) for antipyretics, 39.5 min (p < 0.001) for bronchodilators, and 57.1 min (p < 0.001) for vasodilators. This delay can increase the odds of developing a fever by 32.94%, tachypnea by 79.5%, and hypertension by 134%, respectively. Compared to estimates generated by a naïve regression approach, our IV estimates tend to be higher, suggesting the existence of a bias from providers prioritizing more critical patients. |
format | Online Article Text |
id | pubmed-8774917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87749172022-01-21 The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit Meng, Lesley Laudanski, Krzysztof Restrepo, Mariana Huffenberger, Ann Terwiesch, Christian Healthcare (Basel) Article We estimated the harm related to medication delivery delays across 12,474 medication administration instances in an intensive care unit using retrospective data in a large urban academic medical center between 2012 and 2015. We leveraged an instrumental variables (IV) approach that addresses unobserved confounds in this setting. We focused on nurse shift changes as disruptors of timely medication (vasodilators, antipyretics, and bronchodilators) delivery to estimate the impact of delay. The average delay around a nurse shift change was 60.8 min (p < 0.001) for antipyretics, 39.5 min (p < 0.001) for bronchodilators, and 57.1 min (p < 0.001) for vasodilators. This delay can increase the odds of developing a fever by 32.94%, tachypnea by 79.5%, and hypertension by 134%, respectively. Compared to estimates generated by a naïve regression approach, our IV estimates tend to be higher, suggesting the existence of a bias from providers prioritizing more critical patients. MDPI 2021-12-25 /pmc/articles/PMC8774917/ /pubmed/35052199 http://dx.doi.org/10.3390/healthcare10010035 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Meng, Lesley Laudanski, Krzysztof Restrepo, Mariana Huffenberger, Ann Terwiesch, Christian The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit |
title | The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit |
title_full | The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit |
title_fullStr | The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit |
title_full_unstemmed | The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit |
title_short | The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit |
title_sort | impact of delayed symptomatic treatment implementation in the intensive care unit |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774917/ https://www.ncbi.nlm.nih.gov/pubmed/35052199 http://dx.doi.org/10.3390/healthcare10010035 |
work_keys_str_mv | AT menglesley theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit AT laudanskikrzysztof theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit AT restrepomariana theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit AT huffenbergerann theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit AT terwieschchristian theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit AT menglesley impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit AT laudanskikrzysztof impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit AT restrepomariana impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit AT huffenbergerann impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit AT terwieschchristian impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit |